Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily S&P Biotech Bull 3x Shares

296.31
+0.55000.19%
Post-market: 295.02-1.2900-0.44%19:59 EDT
Volume:260.53K
Turnover:75.10M
Market Cap:570.24M
PE:- -
High:300.34
Open:290.97
Low:281.50
Close:295.76
52wk High:341.93
52wk Low:71.88
Shares:1.92M
Float Shares:1.92M
Volume Ratio:0.69
T/O Rate:13.54%
Dividend:1.01
Dividend Rate:0.34%
ROE:--
ROA:--
PB:--
PE(LYR):- -

Loading ...

Galaxy General Achieves Large-Scale Commercial Deployment in Tourism, Manufacturing, and Healthcare Sectors

Deep News
·
Aug 19

Guangdong Kanghua Healthcare Schedules Board Meeting on Interim Results and Dividend

TIPRANKS
·
Aug 19

Health Care Roundup: Market Talk

Dow Jones
·
Aug 19

Nationwide Healthcare Security Blueprint for the 15th Five-Year Plan: Accelerating the Growth of Commercial Medical Insurance

Stock News
·
Aug 19

Foundation Healthcare Well-Placed to Capture Shift to Lower-Cost Outpatient Care

Dow Jones
·
Aug 19

Does FDA-Backed Mpox mRNA Trial and AstraZeneca Tie-Up Recast the Bull Case For CSPC (SEHK:1093)?

Simply Wall St.
·
Aug 19

MedSci Healthcare Sets August Board Meeting to Approve Interim Results and Dividend Plan

TIPRANKS
·
Aug 19

Promisia Healthcare Corrects Warrant Count After Capital Change

TIPRANKS
·
Aug 19

ASX Midday Sector Update: Healthcare Stocks Jump, Information Technology Sector Struggles

MT Newswires Live
·
Aug 19

Trump Taps Dr. Heidi Overton to Lead FDA

Dow Jones
·
Aug 19

Xspray Pharma Gets FDA Complete Response Letter on Dasynoc, Speeds Manufacturing for 2026 Resubmission

TIPRANKS
·
Aug 19

Analysts Offer Insights on Healthcare Companies: Cogstate Ltd (OtherCOGZF), Pro Medicus Limited (OtherPMCUF) and Cochlear (OtherCHEOF)

TIPRANKS
·
Aug 19

ETF Daily | AAOZ Soars 30%; CBRZ Surges 25%; SOXS Jumps 15%; FNG Plunges 39%; Optical Communications Volatility Leads

ETF Tracker
·
Aug 19

Novartis’ iptacopan granted FDA orphan designation

TIPRANKS
·
Aug 19

Health Care up on Defensive Bias - Health Care Roundup

Dow Jones
·
Aug 19

Health Care Roundup: Market Talk

Dow Jones
·
Aug 19

Replimune Group Lawsuit Focuses on FDA Disclosure Issues and Sharp REPL Stock Drop

TIPRANKS
·
Aug 19

Analyst Reaffirms Buy Rating on Unicycive, Maintaining 12-Month Price Target at $30 After FDA Procedural Setback

TIPRANKS
·
Aug 19

Health Care Roundup: Market Talk

Dow Jones
·
Aug 19

Argenx's Vyvgart Hytrulo Likely to Get FDA Approval for Myositis, RBC Says

MT Newswires Live
·
Aug 18